Trial Outcomes & Findings for Novel Protection Against Potential Brain, Hearing and Vision Injury During Blast Wave Exposure (NCT NCT03017924)

NCT ID: NCT03017924

Last Updated: 2021-02-16

Results Overview

The blast explosive waves experienced during the training during the N-back fMRI testing and the rs fMRI testing

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

single breacher training day

Results posted on

2021-02-16

Participant Flow

Participant milestones

Participant milestones
Measure
Collar Group
Subjects that will wear the Q collar during the breacher training Q collar: q-collar concussion prevention device
Non-Collar Group
Subjects that will not wear the Q collar during the breacher training
Overall Study
STARTED
12
11
Overall Study
COMPLETED
10
8
Overall Study
NOT COMPLETED
2
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Collar Group
n=12 Participants
Subjects that will wear the Q collar during the breacher training Q collar: q-collar concussion prevention device
Non-Collar Group
n=11 Participants
Subjects that will not wear the Q collar during the breacher training
Total
n=23 Participants
Total of all reporting groups
Age, Continuous
39.72 years
STANDARD_DEVIATION 6.79 • n=12 Participants
48.81 years
STANDARD_DEVIATION 10.37 • n=11 Participants
44.27 years
STANDARD_DEVIATION 8.58 • n=23 Participants
Sex: Female, Male
Female
0 Participants
n=12 Participants
0 Participants
n=11 Participants
0 Participants
n=23 Participants
Sex: Female, Male
Male
12 Participants
n=12 Participants
11 Participants
n=11 Participants
23 Participants
n=23 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
12 participants
n=12 Participants
11 participants
n=11 Participants
23 participants
n=23 Participants
Weight
99.10 Kg
STANDARD_DEVIATION 17.58 • n=12 Participants
93.88 Kg
STANDARD_DEVIATION 15.10 • n=11 Participants
96.49 Kg
STANDARD_DEVIATION 16.34 • n=23 Participants

PRIMARY outcome

Timeframe: single breacher training day

Population: some subjects had head motion during the scan

The blast explosive waves experienced during the training during the N-back fMRI testing and the rs fMRI testing

Outcome measures

Outcome measures
Measure
Collar Group
n=10 Participants
Subjects that will wear the Q collar during the breacher training Q collar: q-collar concussion prevention device
Non-Collar Group
n=9 Participants
Subjects that will not wear the Q collar during the breacher training
Blast Explosive Waves Experienced During the Training
Number of blasts N-Back fMRI
4.11 number of blasts
Standard Deviation 3.37
4.29 number of blasts
Standard Deviation 2.06
Blast Explosive Waves Experienced During the Training
Number of blasts rs fMRI
4.20 number of blasts
Standard Deviation 3.19
4.0 number of blasts
Standard Deviation 2.12

PRIMARY outcome

Timeframe: Pre-testing appointment occurred 24-48 hours before breacher training and post test appointment occurred 24-48 hours following breached training.

Population: some subjects had head motion

between group differences in average peak pressure pre to post in collar versus no collar in both N-back fMRI and rfMRI

Outcome measures

Outcome measures
Measure
Collar Group
n=10 Participants
Subjects that will wear the Q collar during the breacher training Q collar: q-collar concussion prevention device
Non-Collar Group
n=9 Participants
Subjects that will not wear the Q collar during the breacher training
Average Peak Pressure Differences Between Groups
rs fMRI Average peak pressure (psi)
1.67 pounds per square inch
Standard Deviation 0.42
1.81 pounds per square inch
Standard Deviation 0.53
Average Peak Pressure Differences Between Groups
N-Back fMRI Average peak pressure (psi)
1.67 pounds per square inch
Standard Deviation 0.44
1.99 pounds per square inch
Standard Deviation 0.41

SECONDARY outcome

Timeframe: Pre-testing appointment occurred 24-48 hours before breacher training and post test appointment occurred 24-48 hours following breached training.

Population: All subject data available for this measure - no data lost due to head motion

between group differences in total impulse pre to post in collar versus no collar in both the n-back fMRI and the rs fMRI testing conditions

Outcome measures

Outcome measures
Measure
Collar Group
n=10 Participants
Subjects that will wear the Q collar during the breacher training Q collar: q-collar concussion prevention device
Non-Collar Group
n=9 Participants
Subjects that will not wear the Q collar during the breacher training
Between Group Differences in Total Impulse Pre to Post in Collar Versus no Collar
n-Back fMRI total impulse
6.58 units on a scale (psi*ms)
Standard Deviation 4.19
7.67 units on a scale (psi*ms)
Standard Deviation 3.31
Between Group Differences in Total Impulse Pre to Post in Collar Versus no Collar
rs FMRI total impulse
6.9 units on a scale (psi*ms)
Standard Deviation 4.08
6.95 units on a scale (psi*ms)
Standard Deviation 3.66

SECONDARY outcome

Timeframe: Pre-testing appointment occurred 24-48 hours before breacher training and post test appointment occurred 24-48 hours following breached training.

Population: all subject data available for this analysis

pre to post training change in the DP-NF value (the dB difference between the distortion product emission and the noise floor amplitudes) between the collar and no collar groups reported in Hz

Outcome measures

Outcome measures
Measure
Collar Group
n=10 Participants
Subjects that will wear the Q collar during the breacher training Q collar: q-collar concussion prevention device
Non-Collar Group
n=9 Participants
Subjects that will not wear the Q collar during the breacher training
Change in DP-NF Value (Reported in Hz)
8000 Hz left
1.13 Change in pre to post Dp (reported in Hz
Standard Deviation 12.21
4.23 Change in pre to post Dp (reported in Hz
Standard Deviation 9.61
Change in DP-NF Value (Reported in Hz)
2000 Hz right
0.98 Change in pre to post Dp (reported in Hz
Standard Deviation 5.10
0.64 Change in pre to post Dp (reported in Hz
Standard Deviation 3.61
Change in DP-NF Value (Reported in Hz)
2000 Hz Left
1.64 Change in pre to post Dp (reported in Hz
Standard Deviation 6.91
-0.5 Change in pre to post Dp (reported in Hz
Standard Deviation 6.91
Change in DP-NF Value (Reported in Hz)
3000 Hz Right
5.15 Change in pre to post Dp (reported in Hz
Standard Deviation 11.36
-1.44 Change in pre to post Dp (reported in Hz
Standard Deviation 6.47
Change in DP-NF Value (Reported in Hz)
3000 Hz Left
2.81 Change in pre to post Dp (reported in Hz
Standard Deviation 10.28
-1.29 Change in pre to post Dp (reported in Hz
Standard Deviation 10.42
Change in DP-NF Value (Reported in Hz)
4000 Hz right
5.63 Change in pre to post Dp (reported in Hz
Standard Deviation 6.48
-2.01 Change in pre to post Dp (reported in Hz
Standard Deviation 6.85
Change in DP-NF Value (Reported in Hz)
4000 Hz left
1.54 Change in pre to post Dp (reported in Hz
Standard Deviation 7.57
2.57 Change in pre to post Dp (reported in Hz
Standard Deviation 6.50
Change in DP-NF Value (Reported in Hz)
6000 Hz right
1.93 Change in pre to post Dp (reported in Hz
Standard Deviation 10.40
-1.29 Change in pre to post Dp (reported in Hz
Standard Deviation 8.88
Change in DP-NF Value (Reported in Hz)
6000 Hz left
-1.68 Change in pre to post Dp (reported in Hz
Standard Deviation 9.6
3.55 Change in pre to post Dp (reported in Hz
Standard Deviation 9.24
Change in DP-NF Value (Reported in Hz)
8000 Hz right
1.43 Change in pre to post Dp (reported in Hz
Standard Deviation 6.97
1.54 Change in pre to post Dp (reported in Hz
Standard Deviation 12.52

Adverse Events

Collar Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Non-Collar Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kim Foss

Cincinnati Childrens Hospital

Phone: 5136365971

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place